Inotiv
Solutions
By Therapeutic Area
Cardiovascular
Gastrointestinal
Hepatic
Infectious Disease
Inflammation and Immunology
Metabolic and Diabetic Disease
Neuroscience
Pulmonary
Oncology
Renal
By Research Phase
Discovery
IND-Enabling
Pre-Marketing Authorization
By Products and Services
Discovery and Translational Sciences
Disease Pharmacology (
in vitro
and
in vivo
)
Drug Metabolism and Pharmacokinetics (DMPK) (
in vitro
and
in vivo
)
Discovery Bioanalysis and Biomarkers
Cell and Molecular Biology
Predictive and Computational Toxicology
Toxicogenomics
Targeted Proteomics
Histology and Pathology
Consultative Drug Discovery Programs
Safety Assessment
Toxicology
Exploratory Toxicology
Genetic Toxicology (GLP and Non-GLP)
Safety Pharmacology
Developmental and Reproductive Toxicology
Carcinogenicity
Pathology
Bioanalysis: Large Molecule (GLP)
Bioanalysis: Small Molecule (GLP)
Impurities Assessment
Archive
Medical Device Testing and Surgical Support
Program Management
SEND
Cell and Gene Therapy
Chemical Services Support
Research Models and Services
Models
Find Research Models
Models by Therapeutic Area
Model Sampling Program
Pricing
Research Services
Genetically Engineered Models and Services (GEMS)
Full Spectrum Health Monitoring
Custom Antibody Production Services
Biospecimen Services
Contract Breeding Services
Genetic Testing Services
Surgical Services
Research Model Support Services
Resources
Eusoft Labs™ (LIMS)
LabTracks™
Teklad™ Diet, Bedding and Enrichment
Teklad Laboratory Animal Diets
Standard Natural Ingredient Diets
Custom Research Diets
Medicated Diets
Bedding and Environmental Enrichment Products
Contact Bedding
Custom-cut Paper Cage Liners
Enrichment Products
Resources
Diet FAQs
Phytoestrogen References
Shelf Life of Diets Used In Research
Ordering
Insights
Scientific Insights
Learn More
Blog
Learn More
Resources
Cell Line References
Eusoft Labs™ (LIMS)
Health Monitoring Reports
LabTracks™
Safety Assessment Publications
Learn More
About
Why Inotiv
Leadership
News and Events
About Cumberland
Environmental, Social and Governance (ESG)
Regulatory Compliance
Global Code of Conduct and Ethics
Animal Welfare Statement
Openness in Animal Research
Global Reach
Company History
General Terms and Conditions of Sales
Cybersecurity Incident Substitute Notice
Careers
Contact
CLOSE
×
×
Home
News and Events
News
Inotiv News
Share this page
Print this page
Filters
Clear all filters
By year
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
December 11, 2025
Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities
December 11, 2025 WEST LAFAYETTE, Ind., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the ...
December 4, 2025
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update
December 3, 2025 – Fourth quarter fiscal 2025 revenue up 5.9% to ...
November 25, 2025
Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
November 25, 2025 Building a Unified, Client-Focused, Early Stage CRO Through Strategic Expansion and Service Development Powers 448% ...
November 21, 2025
Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025
November 21, 2025 WEST LAFAYETTE, Ind., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the ...
November 18, 2025
Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results
November 17, 2025 Preliminary Expected Fourth Quarter 2025 Revenue of $137.5 to $138.5 Million Preliminary ...
October 21, 2025
Inotiv, Inc. to Participate in Three Investor Conferences in November 2025
October 21, 2025 WEST LAFAYETTE, Ind., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: ...
August 13, 2025
Inotiv, Inc. to Participate in Three Investor Conferences in September 2025
August 13, 2025 WEST LAFAYETTE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: ...
August 6, 2025
CORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update
August 6, 2025 In a release issued under the same headline on August 6, 2025 by Inotiv, Inc. (NASDAQ: NOTV), please note that the amount ...
July 30, 2025
Advanced LNP Bioanalysis: Insights Shaping RNA-based Gene Therapy
This article is sponsored by Inotiv. In this VIEWS article, Drug Discovery & ...
July 23, 2025
Inotiv, Inc. to Report Fiscal 2025 Third Quarter Financial Results and Host Conference Call on Wednesday, August 6, 2025
July 23, 2025 WEST LAFAYETTE, Ind., July 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: ...
May 23, 2025
Tapping Into the Full Therapeutic Potential of GLP-1
Dale Wright and Brian Bond from Inotiv discuss the importance of taking a holistic ...
May 8, 2025
Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update
May 7, 2025 — Second quarter fiscal 2025 revenue increased 4.4% to $124.3 million — ...
April 23, 2025
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025
April 23, 2025 WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. ...
February 6, 2025
Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update
February 05, 2025 Enhanced liquidity by ...
January 23, 2025
Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025
May 22, 2025 WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: ...
All posts
Subscribe to updates from Inotiv
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.